Applications of 17A-Ethynyl-1,3,5(10)-Estratriene-3,17B-Diol 3-Methyl Ether in Industrial Manufacturing

As the primary manufacturer, we supply 17A-Ethynyl-1,3,5(10)-Estratriene-3,17B-Diol 3-Methyl Ether to the global pharmaceutical and fine chemical sectors. Our raw material supports advanced hormone drug synthesis, intermediary development, and specialty research applications. Below, you will find detailed industrial application scenarios from actual downstream segments, along with compliance, formulation, and integration insights based on real usage.

1. Synthesis of Estrogenic APIs for Contraceptives

Pharmaceutical manufacturers use our compound to synthesize steroidal estrogens, particularly in oral contraceptive production. The molecular structure enables precise functionalization at the 17α position, supporting downstream esterification and oxidation reactions for specific API targets like ethinylestradiol and related active steroids. Our material meets stringent purity and reaction specificity criteria demanded during pilot and commercial-scale synthesis of finished APIs, ensuring batch reproducibility in continuous reactor and batch vessel systems.

Industry compliance standards

• USP-NF Monographs for APIs
• ICH Q7 GMP Guidelines
• EU Regulation (EC) No 1907/2006 (REACH) for chemical substances
• FDA 21 CFR Part 211: Good Manufacturing Practice for Finished Pharmaceuticals

Typical usage ratio

• 0.8–1.4 molar equivalent relative to target API backbone per batch
• Ratio adjusted based on downstream esterification or methylation steps, with solvent and catalyst loads tailored to process yield optimization

Downstream process integration

• Introduced at stage 2 or 3 of multistep synthesis, following initial steroid nucleus construction
• Used as key reactant in alkylation, azidation, and coupling reactions inside jacketed glass or stainless-steel reactors
• In-line HPLC and GC compliance checks performed after each integration step

Final product types

• Ethinylestradiol active pharmaceutical ingredient (API)
• Combined oral contraceptive tablets
• Emergency contraception pills
• Steroidal hormone injectables

2. Hormone Replacement Therapy (HRT) Intermediate Manufacturing

Major HRT drug facilities transform this compound into intermediates during the synthesis of semi-synthetic estrogenic agents. The methyl-ether protection increases stability and shelf life at sensitive steps, reducing risk of degradation during purification. Process engineers maintain close control of reaction kinetics, as this intermediate impacts the downstream yield and impurity profile of finished HRT drugs. Our supply lot records and impurity spectra align with strict QA/QC benchmarks in regulated pharmaceutical ingredient manufacturing environments.

Industry compliance standards

• EU GMP Directive 2003/94/EC for active substances and intermediates
• Ph. Eur. 10.0 (European Pharmacopoeia) quality attributes
• ICH Q3A/B guidelines for impurity limits in drug substances
• ISO 9001:2015 for quality management systems in chemical manufacturing

Typical usage ratio

• Used at 1.1–1.5 molar equivalents per target HRT intermediate
• Ratio optimized through real-time monitoring of conversion efficiency and downstream deprotection yield

Downstream process integration

• Added post initial saponification or sulfonation to enable ether-protected handling during chromatographic or crystallization purification steps
• Supports scaled-up pilot and commercial workflows employing filtration, distillation, and lyophilization

Final product types

• Estradiol valerate and estradiol cypionate intermediates
• Transdermal patches and gels containing semi-synthetic estrogens
• Tablets and oral suspensions for menopause management
• Compounded pharmacy HRT formulations

3. Specialty Steroidal Analytical Reference Material Preparation

Analytical laboratories and secondary API producers employ this material in preparing certified reference standards for steroid hormone analysis. High structural purity and consistent lot-to-lot specification allow direct use to formulate reference blends for HPLC, GC-MS, and LC-MS/MS calibration. Our validated manufacturing controls maintain traceability and stability for ISO 17034-certified reference material producers, supporting accurate quantification and regulatory submission data in pharmaceutical and doping control labs.

Industry compliance standards

• ISO 17034:2016 for reference material producers
• ISO/IEC 17025:2017 Testing and calibration laboratory accreditation
• European Medicines Agency (EMA) requirements for reference standards
• FDA requirements for analytical standards in NDAs

Typical usage ratio

• Diluted to 1–1000 μg/mL or as specified by the analytical protocol
• Concentration standards prepared in exact accordance with instrument calibration needs and matrix matching

Downstream process integration

• Dissolved and aliquoted into reference solutions for instrument calibration and system suitability testing
• Direct blending with co-eluting steroid standards during method development
• Supports preparation of working and internal standards for commercial HPLC and GC applications

Final product types

• Certified analytical reference standards (CRMs)
• Instrument calibration and system suitability check vials
• Multicomponent steroid QC panels
• Pharmacological validation kits for regulatory submissions

4. Research-Grade Synthesis for Academic and Exploratory Studies

University laboratories, contract research organizations, and biotech innovation centers utilize this compound to study estrogen receptor function, metabolism, and biosynthetic pathways. The compound’s methyl ether group allows structure-activity investigation with minimal side reactions, especially in receptor binding studies and metabolic profiling. Supply batches comply with material disclosure demands for grant-funded and peer-reviewed research, while our impurity profiles support advanced spectroscopic analysis and structure confirmation.

Industry compliance standards

• OECD Guidelines for the Testing of Chemicals
• Material Safety Data Sheet (MSDS) and hazard communication under GHS
• Institutional Chemical Safety Committee protocols
• National Institutes of Health (NIH) grant requirements

Typical usage ratio

• Utilized at 5–500 μM stock solutions in cell-based assay systems or metabolic incubations
• Concentration determined based on endpoint application in receptor binding or enzymatic conversion kinetics

Downstream process integration

• Dissolved in DMSO, methanol, or acetonitrile for use as parent compound in bioassays and in vitro studies
• Directly modified via alkylation, sulfonation, or conjugation for functional analysis
• Integrated into LC-MS profiling pipelines to elucidate breakdown products and metabolites

Final product types

• Cell receptor binding assay reagents
• In vitro pharmacokinetic assay standards
• Metabolite profiling panels for academic research publications
• Custom labeled probe molecules for biosynthetic studies